{"id":12587,"date":"2020-08-01T08:56:10","date_gmt":"2020-08-01T16:56:10","guid":{"rendered":"https:\/\/drugpolicy.ca\/?p=12587"},"modified":"2021-11-07T14:20:18","modified_gmt":"2021-11-07T22:20:18","slug":"convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud","status":"publish","type":"post","link":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/","title":{"rendered":"Convergent risk of COVID-19 and bacterial and viral infections among PWUD"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><p style=\"margin-top:-20px; color:white\">viral and bacterial infections and covid-19, viral and bacterial infections and covid-19<\/p><\/p>\n\n\n\n<iframe loading=\"lazy\" class=\"scribd_iframe_embed\" title=\"Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs\" src=\"https:\/\/www.scribd.com\/embeds\/471102709\/content?start_page=1&amp;view_mode=scroll&amp;access_key=key-DOjToHlIGrGZsSaOuyyv\" data-auto-height=\"false\" data-aspect-ratio=\"0.7504159733777038\" scrolling=\"no\" id=\"doc_80683\" width=\"100%\" height=\"600\" frameborder=\"0\"><\/iframe>\n\n\n\n<div style=\"height:15px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-background\" href=\"\" style=\"background-color:#c42127\" target=\"_blank\" rel=\"noreferrer noopener\">Download PDF<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:11px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p style=\"text-align:center\"><strong>Click <a href=\"https:\/\/drugpolicy.ca\/covid-19-harm-reduction-resources\/\" target=\"_blank\" aria-label=\"undefined (opens in a new tab)\" rel=\"noreferrer noopener\">HERE<\/a> for more resources<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;Without adequate access to harm reduction interventions, PWUD are potentially at greater risk of acquiring blood-borne viruses (BBVs) and severe bacterial infections. Individual, social, and structural determinants of health (e.g., unstable housing, incarceration, poverty, drug criminalization) associated with increased risk for bacterial infections and BBVs will likely place PWUD at greater risk of COVID-19 disease and death.&#8221;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Source: <a aria-label=\"undefined (opens in a new tab)\" href=\"https:\/\/www.journals.elsevier.com\/international-journal-of-drug-policy\" target=\"_blank\" rel=\"noreferrer noopener\">International Journal of Drug Policy<\/a><\/em><\/p>\n\n\n\n<div class=\"widget signup-widget mb-5\">\r\n<p class=\"lead\"><strong>\u00cates-vous pr\u00eat(e) \u00e0 aider ?<\/strong><\/p>\r\n<p>Soutenez des politiques sur les drogues bas\u00e9es sur la justice sociale, la compassion et les preuves. Inscrivez-vous \u00e0 notre newsletter pour obtenir des mises \u00e0 jour et d\u00e9couvrez comment vous pouvez agir avec nous.<\/p>\r\n<!-- form.123formbuilder.com script begins here --><script type=\"text\/javascript\" defer=\"defer\" src=\"https:\/\/form.123formbuilder.com\/embed\/6415583.js\" data-role=\"form\" data-default-width=\"650px\"><\/script><!-- form.123formbuilder.com script ends here -->\r\n<\/div>\r\n\n\n\n<ul class=\"wp-block-social-links aligncenter is-style-default is-layout-flex wp-block-social-links-is-layout-flex\"><li class=\"wp-social-link wp-social-link-twitter  wp-block-social-link\"><a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.twitter.com\/candrugpolicy\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M22.23,5.924c-0.736,0.326-1.527,0.547-2.357,0.646c0.847-0.508,1.498-1.312,1.804-2.27 c-0.793,0.47-1.671,0.812-2.606,0.996C18.324,4.498,17.257,4,16.077,4c-2.266,0-4.103,1.837-4.103,4.103 c0,0.322,0.036,0.635,0.106,0.935C8.67,8.867,5.647,7.234,3.623,4.751C3.27,5.357,3.067,6.062,3.067,6.814 c0,1.424,0.724,2.679,1.825,3.415c-0.673-0.021-1.305-0.206-1.859-0.513c0,0.017,0,0.034,0,0.052c0,1.988,1.414,3.647,3.292,4.023 c-0.344,0.094-0.707,0.144-1.081,0.144c-0.264,0-0.521-0.026-0.772-0.074c0.522,1.63,2.038,2.816,3.833,2.85 c-1.404,1.1-3.174,1.756-5.096,1.756c-0.331,0-0.658-0.019-0.979-0.057c1.816,1.164,3.973,1.843,6.29,1.843 c7.547,0,11.675-6.252,11.675-11.675c0-0.178-0.004-0.355-0.012-0.531C20.985,7.47,21.68,6.747,22.23,5.924z\"><\/path><\/svg><span class=\"wp-block-social-link-label screen-reader-text\">Twitter<\/span><\/a><\/li>\n\n<li class=\"wp-social-link wp-social-link-facebook  wp-block-social-link\"><a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.facebook.com\/candrugpolicy\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M12 2C6.5 2 2 6.5 2 12c0 5 3.7 9.1 8.4 9.9v-7H7.9V12h2.5V9.8c0-2.5 1.5-3.9 3.8-3.9 1.1 0 2.2.2 2.2.2v2.5h-1.3c-1.2 0-1.6.8-1.6 1.6V12h2.8l-.4 2.9h-2.3v7C18.3 21.1 22 17 22 12c0-5.5-4.5-10-10-10z\"><\/path><\/svg><span class=\"wp-block-social-link-label screen-reader-text\">Facebook<\/span><\/a><\/li>\n\n<li class=\"wp-social-link wp-social-link-instagram  wp-block-social-link\"><a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.instagram.com\/candrugpolicy\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M12,4.622c2.403,0,2.688,0.009,3.637,0.052c0.877,0.04,1.354,0.187,1.671,0.31c0.42,0.163,0.72,0.358,1.035,0.673 c0.315,0.315,0.51,0.615,0.673,1.035c0.123,0.317,0.27,0.794,0.31,1.671c0.043,0.949,0.052,1.234,0.052,3.637 s-0.009,2.688-0.052,3.637c-0.04,0.877-0.187,1.354-0.31,1.671c-0.163,0.42-0.358,0.72-0.673,1.035 c-0.315,0.315-0.615,0.51-1.035,0.673c-0.317,0.123-0.794,0.27-1.671,0.31c-0.949,0.043-1.233,0.052-3.637,0.052 s-2.688-0.009-3.637-0.052c-0.877-0.04-1.354-0.187-1.671-0.31c-0.42-0.163-0.72-0.358-1.035-0.673 c-0.315-0.315-0.51-0.615-0.673-1.035c-0.123-0.317-0.27-0.794-0.31-1.671C4.631,14.688,4.622,14.403,4.622,12 s0.009-2.688,0.052-3.637c0.04-0.877,0.187-1.354,0.31-1.671c0.163-0.42,0.358-0.72,0.673-1.035 c0.315-0.315,0.615-0.51,1.035-0.673c0.317-0.123,0.794-0.27,1.671-0.31C9.312,4.631,9.597,4.622,12,4.622 M12,3 C9.556,3,9.249,3.01,8.289,3.054C7.331,3.098,6.677,3.25,6.105,3.472C5.513,3.702,5.011,4.01,4.511,4.511 c-0.5,0.5-0.808,1.002-1.038,1.594C3.25,6.677,3.098,7.331,3.054,8.289C3.01,9.249,3,9.556,3,12c0,2.444,0.01,2.751,0.054,3.711 c0.044,0.958,0.196,1.612,0.418,2.185c0.23,0.592,0.538,1.094,1.038,1.594c0.5,0.5,1.002,0.808,1.594,1.038 c0.572,0.222,1.227,0.375,2.185,0.418C9.249,20.99,9.556,21,12,21s2.751-0.01,3.711-0.054c0.958-0.044,1.612-0.196,2.185-0.418 c0.592-0.23,1.094-0.538,1.594-1.038c0.5-0.5,0.808-1.002,1.038-1.594c0.222-0.572,0.375-1.227,0.418-2.185 C20.99,14.751,21,14.444,21,12s-0.01-2.751-0.054-3.711c-0.044-0.958-0.196-1.612-0.418-2.185c-0.23-0.592-0.538-1.094-1.038-1.594 c-0.5-0.5-1.002-0.808-1.594-1.038c-0.572-0.222-1.227-0.375-2.185-0.418C14.751,3.01,14.444,3,12,3L12,3z M12,7.378 c-2.552,0-4.622,2.069-4.622,4.622S9.448,16.622,12,16.622s4.622-2.069,4.622-4.622S14.552,7.378,12,7.378z M12,15 c-1.657,0-3-1.343-3-3s1.343-3,3-3s3,1.343,3,3S13.657,15,12,15z M16.804,6.116c-0.596,0-1.08,0.484-1.08,1.08 s0.484,1.08,1.08,1.08c0.596,0,1.08-0.484,1.08-1.08S17.401,6.116,16.804,6.116z\"><\/path><\/svg><span class=\"wp-block-social-link-label screen-reader-text\">Instagram<\/span><\/a><\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Without access to harm reduction, PWUD are potentially at greater risk of acquiring blood-borne viruses<\/p>\n","protected":false},"author":38,"featured_media":12585,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1120],"tags":[1126],"class_list":["post-12587","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-research","tag-miscellaneous"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Convergent risk of COVID-19 and bacterial and viral infections among PWUD - Canadian Drug Policy Coalition<\/title>\n<meta name=\"description\" content=\"Without access to harm reduction, PWUD are potentially at greater risk of acquiring blood-borne viruses | viral and bacterial infections and covid-19\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Convergent risk of COVID-19 and bacterial and viral infections among PWUD - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"Without access to harm reduction, PWUD are potentially at greater risk of acquiring blood-borne viruses | viral and bacterial infections and covid-19\" \/>\n<meta property=\"og:url\" content=\"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-01T16:56:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-07T22:20:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2020\/08\/Screen-Shot-2020-08-01-at-9.37.21-AM.png\" \/>\n\t<meta property=\"og:image:width\" content=\"863\" \/>\n\t<meta property=\"og:image:height\" content=\"674\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Canadian Drug Policy Coalition\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/\"},\"author\":{\"name\":\"Canadian Drug Policy Coalition\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\"},\"headline\":\"Convergent risk of COVID-19 and bacterial and viral infections among PWUD\",\"datePublished\":\"2020-08-01T16:56:10+00:00\",\"dateModified\":\"2021-11-07T22:20:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/\"},\"wordCount\":94,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/Screen-Shot-2020-08-01-at-9.37.21-AM.png\",\"keywords\":[\"miscellaneous\"],\"articleSection\":[\"covid research\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/\",\"name\":\"Convergent risk of COVID-19 and bacterial and viral infections among PWUD - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/Screen-Shot-2020-08-01-at-9.37.21-AM.png\",\"datePublished\":\"2020-08-01T16:56:10+00:00\",\"dateModified\":\"2021-11-07T22:20:18+00:00\",\"description\":\"Without access to harm reduction, PWUD are potentially at greater risk of acquiring blood-borne viruses | viral and bacterial infections and covid-19\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/#primaryimage\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/Screen-Shot-2020-08-01-at-9.37.21-AM.png\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/Screen-Shot-2020-08-01-at-9.37.21-AM.png\",\"width\":863,\"height\":674},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Convergent risk of COVID-19 and bacterial and viral infections among PWUD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\",\"name\":\"Canadian Drug Policy Coalition\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"caption\":\"Canadian Drug Policy Coalition\"},\"description\":\"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/author\\\/canadian-drug-policy-coalition\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Convergent risk of COVID-19 and bacterial and viral infections among PWUD - Canadian Drug Policy Coalition","description":"Without access to harm reduction, PWUD are potentially at greater risk of acquiring blood-borne viruses | viral and bacterial infections and covid-19","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/","og_locale":"fr_FR","og_type":"article","og_title":"Convergent risk of COVID-19 and bacterial and viral infections among PWUD - Canadian Drug Policy Coalition","og_description":"Without access to harm reduction, PWUD are potentially at greater risk of acquiring blood-borne viruses | viral and bacterial infections and covid-19","og_url":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2020-08-01T16:56:10+00:00","article_modified_time":"2021-11-07T22:20:18+00:00","og_image":[{"width":863,"height":674,"url":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2020\/08\/Screen-Shot-2020-08-01-at-9.37.21-AM.png","type":"image\/png"}],"author":"Canadian Drug Policy Coalition","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Canadian Drug Policy Coalition","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/#article","isPartOf":{"@id":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/"},"author":{"name":"Canadian Drug Policy Coalition","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30"},"headline":"Convergent risk of COVID-19 and bacterial and viral infections among PWUD","datePublished":"2020-08-01T16:56:10+00:00","dateModified":"2021-11-07T22:20:18+00:00","mainEntityOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/"},"wordCount":94,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/08\/Screen-Shot-2020-08-01-at-9.37.21-AM.png","keywords":["miscellaneous"],"articleSection":["covid research"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/","url":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/","name":"Convergent risk of COVID-19 and bacterial and viral infections among PWUD - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/#primaryimage"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/08\/Screen-Shot-2020-08-01-at-9.37.21-AM.png","datePublished":"2020-08-01T16:56:10+00:00","dateModified":"2021-11-07T22:20:18+00:00","description":"Without access to harm reduction, PWUD are potentially at greater risk of acquiring blood-borne viruses | viral and bacterial infections and covid-19","breadcrumb":{"@id":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/#primaryimage","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/08\/Screen-Shot-2020-08-01-at-9.37.21-AM.png","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/08\/Screen-Shot-2020-08-01-at-9.37.21-AM.png","width":863,"height":674},{"@type":"BreadcrumbList","@id":"https:\/\/drugpolicy.ca\/fr\/convergent-risk-of-covid-19-and-bacterial-and-viral-infections-among-pwud\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Convergent risk of COVID-19 and bacterial and viral infections among PWUD"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30","name":"Canadian Drug Policy Coalition","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","caption":"Canadian Drug Policy Coalition"},"description":"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice","url":"https:\/\/drugpolicy.ca\/fr\/author\/canadian-drug-policy-coalition\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/12587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=12587"}],"version-history":[{"count":16,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/12587\/revisions"}],"predecessor-version":[{"id":16986,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/12587\/revisions\/16986"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/12585"}],"wp:attachment":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=12587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=12587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=12587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}